nivolumab,ipilimumab,cabozantinib
bms,exelixis
['triplet,(-triplete)', 'cosmic313']
great conclusion of #cosmic313 from .
moving forward with non-overlspping toxicity triplets. #esmo22 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert